Cargando…

Pharmacokinetics-based identification of pseudoaldosterogenic compounds originating from Glycyrrhiza uralensis roots (Gancao) after dosing LianhuaQingwen capsule

LianhuaQingwen capsule, prepared from an herbal combination, is officially recommended as treatment for COVID-19 in China. Of the serial pharmacokinetic investigations we designed to facilitate identifying LianhuaQingwen compounds that are likely to be therapeutically important, the current investig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lan, Xiao-fang, Olaleye, Olajide E., Lu, Jun-lan, Yang, Wei, Du, Fei-fei, Yang, Jun-ling, Cheng, Chen, Shi, Yan-hong, Wang, Feng-qing, Zeng, Xue-shan, Tian, Nan-nan, Liao, Pei-wei, Yu, Xuan, Xu, Fang, Li, Ying-fei, Wang, Hong-tao, Zhang, Nai-xia, Jia, Wei-wei, Li, Chuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086230/ https://www.ncbi.nlm.nih.gov/pubmed/33931765 http://dx.doi.org/10.1038/s41401-021-00651-2

Ejemplares similares

The mechanisms and clinical application of Traditional Chinese Medicine Lianhua-Qingwen capsule
por: Shen, Xuhui, et al.
Publicado: (2021)

Lianhua Qingwen prescription for Coronavirus disease 2019 (COVID-19) treatment: Advances and prospects
por: Li, Liu-Cheng, et al.
Publicado: (2020)

Effectiveness and Safety of Lianhua Qingwen Capsules for COVID-19: A Propensity-Score Matched Cohort Study
por: Lu, Yun, et al.
Publicado: (2023)

Mechanisms Underlying the Effects of Lianhua Qingwen on Sepsis-Induced Acute Lung Injury: A Network Pharmacology Approach
por: Yang, Ruhao, et al.
Publicado: (2021)

Meta-analysis on the effect of combining Lianhua Qingwen with Western medicine to treat coronavirus disease 2019
por: Wang, Deng-chao, et al.
Publicado: (2022)

The immunostimulatory activity of polysaccharides from Glycyrrhiza uralensis
por: Aipire, Adila, et al.
Publicado: (2020)

Efficacy and Safety of Lianhua Qingwen for Patients with COVID-19: A Systematic Review and Meta-Analysis
por: Sun, Xiao-hu, et al.
Publicado: (2022)

Predicting for anti-(mutant) SARS-CoV-2 and anti-inflammation compounds of Lianhua Qingwen Capsules in treating COVID-19
por: Hong, Liang, et al.
Publicado: (2022)

Establishment of an anti-inflammation-based bioassay for the quality control of the 13-component TCM formula (Lianhua Qingwen)
por: Chen, Shuaishuai, et al.
Publicado: (2021)

The Adverse Reactions of Lianhua Qingwen Capsule/Granule Compared With Conventional Drug in Clinical Application: A Meta-Analysis
por: Hu, Caiyun, et al.
Publicado: (2022)

Screening for Anti-Inflammation Quality Markers of Lianhua Qingwen Capsule Based on Network Pharmacology, UPLC, and Biological Activity
por: Zhou, Yongfeng, et al.
Publicado: (2021)

A meta-analysis for Lianhua Qingwen on the treatment of Coronavirus disease 2019 (COVID-19)
por: Zhuang, Jieqin, et al.
Publicado: (2021)

An umbrella review of Lianhua Qingwen combined with Western medicine for the treatment of coronavirus disease 2019
por: Yang, Kelu, et al.
Publicado: (2022)

Spectrum-Effect Relationships of Flavonoids in Glycyrrhiza uralensis Fisch.
por: Li, Tingting, et al.
Publicado: (2020)

Qualitative and Quantitative Analysis of the Major Constituents in Chinese Medical Preparation Lianhua-Qingwen Capsule by UPLC-DAD-QTOF-MS
por: Jia, Weina, et al.
Publicado: (2015)

Qualitative analysis of chemical components in Lianhua Qingwen capsule by HPLC-Q Exactive-Orbitrap-MS coupled with GC-MS
por: Fu, Shuai, et al.
Publicado: (2021)

Deciphering suppressive effects of Lianhua Qingwen Capsule on COVID-19 and synergistic effects of its major botanical drug pairs
por: CHEN, Yuanyuan, et al.
Publicado: (2023)

Efficacy and Safety of Chinese Medicine Lianhua Qingwen for Treating COVID-19: An Updated meta-Analysis
por: Li, Yapeng, et al.
Publicado: (2022)

The complete mitochondrial genome of Glycyrrhiza uralensis Fisch. (Fabales, Leguminosae)
por: Yang, Yan-Yun, et al.
Publicado: (2021)

Efficacy of Lianhua Qingwen for children with SARS-CoV-2 Omicron infection: A propensity score-matched retrospective cohort study
por: Xu, Xiangru, et al.
Publicado: (2023)

Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID‐19
por: Xia, Qi‐Dong, et al.
Publicado: (2020)

Intestinal microbiota analysis and network pharmacology reveal the mechanism by which Lianhua Qingwen capsule improves the immune function of mice infected with influenza A virus
por: Xu, Ping, et al.
Publicado: (2022)

Efficacy and safety of Lianhua Qingwen capsules, a repurposed Chinese herb, in patients with Coronavirus disease 2019: A multicenter, prospective, randomized controlled trial [Phytomedicine 85 (2021) 153242]
por: Hu, Ke, et al.
Publicado: (2022)

Exploration of the Mechanism of Lianhua Qingwen in Treating Influenza Virus Pneumonia and New Coronavirus Pneumonia with the Concept of “Different Diseases with the Same Treatment” Based on Network Pharmacology
por: Su, Huihui, et al.
Publicado: (2022)

Lianhua Qingwen Capsules Reduced the Rate of Severity in Patients with COVID-19: A System Review and Meta-Analysis of Randomized Controlled Trials
por: Shi, Chengqian, et al.
Publicado: (2022)

The efficacy and safety of Lianhua Qingwen (LHQW) for coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta analysis
por: Zhang, Qiongshuai, et al.
Publicado: (2020)

The Effects of Endogenous Hormones on the Flowering and Fruiting of Glycyrrhiza uralensis
por: Yan, Binbin, et al.
Publicado: (2019)

Efficacy and safety of Lianhua Qingwen capsules combined with standard of care in the treatment of adult patients with mild to moderate COVID-19 (FLOSAN): protocol for a randomized, double-blind, international multicenter clinical trial
por: Zhan, Yang-Qing, et al.
Publicado: (2023)

Molecular docking and molecular dynamics study Lianhua Qingwen granules (LHQW) treats COVID-19 by inhibiting inflammatory response and regulating cell survival
por: Cao, Jun-Feng, et al.
Publicado: (2022)

Preparation, Characterization, and Immuno-Enhancing Activity of Polysaccharides from Glycyrrhiza uralensis
por: Aipire, Adila, et al.
Publicado: (2020)

Anti-rotaviral effects of Glycyrrhiza uralensis extract in piglets with rotavirus diarrhea
por: Alfajaro, Mia Madel, et al.
Publicado: (2012)

Correlation analysis between the rate of respiration in the root and the active components in licorice (Glycyrrhiza uralensis)
por: GUO, PEIJUN, et al.
Publicado: (2014)

Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: A randomized controlled trial
por: Xiao, Mingzhong, et al.
Publicado: (2020)

Efficacy of Lianhua Qingwen Compared with Conventional Drugs in the Treatment of Common Pneumonia and COVID-19 Pneumonia: A Meta-Analysis
por: Hu, Caiyun, et al.
Publicado: (2020)

GURFAP: A Platform for Gene Function Analysis in Glycyrrhiza Uralensis
por: Yang, Jiaotong, et al.
Publicado: (2022)

Identification of Long Non-coding RNA Transcripts in Glycyrrhiza uralensis
por: Rostami Azar, Arash, et al.
Publicado: (2022)

Inhibition of Soluble Epoxide Hydrolase Activity by Components of Glycyrrhiza uralensis
por: Kim, Jang Hoon, et al.
Publicado: (2023)

Traditional Chinese medicine Lianhua Qingwen for treating COVID-19: A protocol for a meta-analysis and systematic review of randomized controlled trials
por: Li, Shasha, et al.
Publicado: (2021)

Efficacy and safety of Lianhua Qingwen in the treatment of patients with moderate COVID-19 infection: A protocol for systematic review and meta analysis
por: Liu, Nanyang, et al.
Publicado: (2020)

Network pharmacology and computer-aided drug design to explored potential targets of Lianhua Qingwen and Qingfei Paidu decoction for COVID-19
por: Li, Liyuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5rp7ldo4pvrlqca8vl16n4t9k7